Removing or restoring the Rett syndrome gene, MeCP2, in two mouse neuron types reveals that each type underlies distinct features of the condition1,2. The findings suggest that therapies designed to treat Rett syndrome should target neurons that boost brain activity as well as those that inhibit it.…